参考文献/References:
[1] Japan nephrology society. Clinical practice guidebook for diagnosis and treatment of
chronic kidney disease 2012[J].Nihon Jinzo Gakkai Shi,2012,54(8):1034-1191.
[2] Wada T, Shimizu M, Toyama T, et al. Clinical impact of albuminuria in diabetic nephropathy
[J].Clin Exp Nephrol,2012,16(1):96-101. DOI: 10.1007/s10157-011-0508-z.
[3] Levey AS, de Jong PE, Coresh J,et al. The definition, classification, and prognosis of
chronic kidney disease: a KDIGO controversies conference report[J].Kidney Int,2011,80(1):17-28.
DOI: 10.1038/ki.2010.483.
[4] Molitch ME, Steffes M, Sun W,et al. Development and progression of renal insufficiency with
and without albuminuria in adults with type 1 diabetes in the diabetes control and complications
trial and the epidemiology of diabetes interventions and complications study[J].Diabetes
Care,2010,33(7):1536-1543. DOI: 10.2337/dc09-1098.
[5] Yokoyama H, Sone H, Oishi M,et al. Prevalence of albuminuria and renal insufficiency and
associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management
study(JDDM15)[J].Nephrol Dial Transplant,2009,24(4):1212-1219. DOI: 10.1093/ndt/gfn603.
[6] Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal
impairment in type 2 diabetes[J].J Hypertens,2011,29(9):1802-1809. DOI:
10.1097/HJH.0b013e3283495cd6.
[7] Taniwaki H, Nishizawa Y, Kawagishi T,et al. Decrease in glomerular filtration rate in
Japanese patients with type 2 diabetes is linked to atherosclerosis[J].Diabetes Care,1998,21
(11):1848-1855.
[8] MacIsaac RJ, Panagiotopoulos S, McNeil KJ,et al. Is nonalbuminuric renal insufficiency in
type 2 diabetes related to an increase in intrarenal vascular disease?[J].Diabetes Care,2006,29
(7):1560-1566.
[9] Macisaac RJ, Jerums G. Diabetic kidney disease with and without albuminuria[J].Curr Opin
Nephrol Hypertens,2011,20(3):246-257. DOI: 10.1097/MNH.0b013e3283456546.
[10] Rigalleau V, Lasseur C, Raffaitin C, et al. Normoalbuminuric renal-insufficient diabetic
patients: a lower-risk group[J].Diabetes Care,2007,30(8):2034-2039.
[11] Lane PH, Steffes MW, Mauer SM. Glomerular structure in IDDM women with low glomerular
filtration rate and normal urinary albumin excretion[J].Diabetes,1992,41(5):581-586.
[12] Yagil C, Barak A, Ben-Dor D, et al. Nonproteinuric diabetes-associated nephropathy in the
Cohen rat model of type 2 diabetes[J].Diabetes,2005,54(5):1487-1496.
[13] Shimizu M, Furuichi K, Toyama T, et al. Long-term outcomes of Japanese type 2 diabetic
patients with biopsy-proven diabetic nephropathy[J].Diabetes Care,2013,36(11):3655-3662. DOI:
10.2337/dc13-0298.
[14] Mora-Fernández C, Domínguez-Pimentel V, de Fuentes MM, et al. Diabetic kidney disease:
from physiology to therapeutics[J].J Physiol,2014,592(18):3997-4012. DOI:
10.1113/jphysiol.2014.272328.
[15] Bruno G, Merletti F, Bargero G,et al. Estimated glomerular filtration rate, albuminuria and
mortality in type 2 diabetes: the Casale Monferrato study[J].Diabetologia,2007,50(5):941-948.
[16] Babazono T, Nyumura I, Toya K,et al. Higher levels of urinary albumin excretion within the
normal range predict faster decline in glomerular filtration rate in diabetic patients
[J].Diabetes Care,2009,32(8):1518-1520. DOI: 10.2337/dc08-2151.
[17] Ruggenenti P, Porrini E, Motterlini N,et al. Measurable urinary albumin predicts
cardiovascular risk among normoalbuminuric patients with type 2 diabetes[J].J Am Soc
Nephrol,2012,23(10):1717-1724.DOI:10.1681/ASN.2012030252.
[18] Ninomiya T, Perkovic V, de Galan BE,et al. Albuminuria and kidney function independently
predict cardiovascular and renal outcomes in diabetes[J].J Am Soc Nephrol,2009,20(8):1813-1821.
DOI: 10.1681/ASN.2008121270.
[19] Yokoyama H, Oishi M, Kawai K, et al. Reduced GFR and microalbuminuria are independently
associated with prevalent cardiovascular disease in type 2 diabetes: JDDM study 16[J].Diabet
Med,2008,25(12):1426-1432.DOI: 10.1111/j.1464-5491.2008.02592.x.
[20] Toyama T, Furuichi K, Ninomiya T, et al. The impacts of albuminuria and low eGFR on the
risk of cardiovascular death, all-cause mortality, and renalevents in diabetic patients: meta-
analysis[J].PLoS One,2013,8(8):e71810. DOI: 10.1371/journal.pone.0071810.
相似文献/References:
[1].2007年糖尿病新进展学习班将举办[J].国际内分泌代谢杂志,2007,(04):226.
[2]李英,段惠军.Raf/MEK/ERK信号转导通路在糖尿病肾病发生发展中的作用[J].国际内分泌代谢杂志,2007,(04):264.
[3]张红 章向成 朱大龙.炎性反应与糖尿病肾病[J].国际内分泌代谢杂志,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
Zhang Hong*,Zhang Xiangcheng,Zhu Dalong..Role of inflammation in diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
[4]邵滢,王秋月.Mir-217/Sirt1通路与糖尿病肾病[J].国际内分泌代谢杂志,2015,(02):124.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
Shao Ying,Wang Qiuyue..Mir-217 / Sirt1 pathway and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):124.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
[5]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[6]任慧雯,王秋月.Epac-Rap1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):170.[doi:10.3760/cma.j.issn.1673-4157.2015.03.007]
Ren Huiwen,Wang Qiuyue..Epac-Rap1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):170.[doi:10.3760/cma.j.issn.1673-4157.2015.03.007]
[7]邵滢,王秋月.MiRNA-150与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
Shao Ying,Wang Qiuyue..MiRNA-150 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
[8]陈堃,刘超,陈国芳,等.糖尿病肾病诊断标志物研究进展[J].国际内分泌代谢杂志,2015,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2015.03.009]
Chen Kun,Liu Chao,Chen Guofang,et al.Urinary biomarkers for diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):176.[doi:10.3760/cma.j.issn.1673-4157.2015.03.009]
[9]任慧雯,王秋月.Vasohibin-1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(04):246.[doi:10.3760/cma.j.issn.1673-4157.2015.04.008]
Ren Huiwen,Wang Qiuyue..Vasohibin-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):246.[doi:10.3760/cma.j.issn.1673-4157.2015.04.008]
[10]安丽,王秋月.Visfatin与胰岛素抵抗及糖尿病肾病的发病机制[J].国际内分泌代谢杂志,2015,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]
An Li,Wang Qiuyue..Visfatin in the pathogenesis of insulin resistance and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]